|
I-Catalyst Program - Travelers Health with Travel Industry |
GenIC Submission under OMB #0920-1158 |
Juliana K. Cyril, MPH, PhD Director, Office of Technology and Innovation Office of the Associate Director for Science Centers for Disease Control and Prevention Ph: 404-639-4639 Fax: 404-639-4903
Team Lead – Ryan Lash, NCEZID
Submission Date: 10-13-2017
|
1. Circumstances Making the Collection of Information Necessary 3
2. Purpose and Use of Information Collection 3
3. Use of Improved Information Technology and Burden Reduction 4
4. Efforts to Identify Duplication and Use of Similar Information 4
5. Impact on Small Businesses or Other Small Entities 5
6. Consequences of Collecting the Information Less Frequently 5
7. Special Circumstances Relating to the Guidelines of 5 CFR 1320.5 5
8. Comments in Response to the Federal Register Notice and Efforts to Consult Outside the Agency 5
9. Explanation of Any Payment or Gift to Respondents 5
10. Assurance of Confidentiality Provided to Respondents 5
11. Justification for Sensitive Questions 5
12. Estimates of Annualized Burden Hours and Costs 5
13. Estimates of Other Total Annual Cost Burden to Respondents or Record Keepers 6
14. Annualized Cost to the Government 6
15. Explanation for Program Changes or Adjustments 6
16. Plans for Tabulation and Publication and Project Time Schedule 6
17. Reason(s) Display of OMB Expiration Date is Inappropriate 6
18. Exceptions to Certification for Paperwork Reduction Act Submissions 6
GenIC Package & Attachments
Supporting Statement A
Att. 1: I-Cat Interview Protocol Guide and Questions
Template Request for Approval GenIC Clearance
The team at Division of Global
Migration and Quarantine is seeking feedback from third party
stakeholders about how best to optimize CDC content for their
customers, and mechanisms by which they would prefer to receive and
engage with CDC content. DGMQ hope to gain insights into best
practices for delivering timely, accurate information to third
party users that can easily be distributed to the traveler and
clinician audiences.
The CDC project team will conduct
30-minute, semi-structured interviews with respondents in the
travel industry. Teams will use convenience sampling methods to
select subjects who are readily available and within close
proximity.
Populations and customers to be
interviewed Private Sector - Business or other for-profits include
travel writers and bloggers; any individuals involved in developing
and promoting travel-related website or apps; travel agents; and
other groups in the international travel industry.
Resulting data
will be used for internal CDC Division of Global Migration and
Quarantine discussion and decision-making. The project
hopes to clarify information and to make travel health advice
actionable and easy to understand.
Data from the semi-structured
interviews will identify themes or repeated insights/feedback from
the stakeholders. Traveler Health will perform simple analysis
techniques to group, organize, and identify themes in the
information collected. No statistical analyses will be performed.
All CDC Travelers’ Health (TH) content published to our website is in the public domain, and as such, any third party is able to copy and republish this content. In fact, some commercial travel health information and international health and safety update providers are already engaging in this activity. This can be seen as a way to amplify CDC’s messaging, as external information providers may have a larger audience than the CDC website, and may be able to reach audience members who would otherwise be unaware of CDC information. However, currently CDC has no way of ensuring that third party users are providing the most accurate and up-to-date information to their audience, because each one is responsible for copying and then maintaining CDC TH content. CDC also cannot know if the currently available content provided on our website is attractive to third party users as a resource to meet their customer needs. Further, CDC has no way of tracking the ultimate reach of messaging when and if provided to customers by a third party. We would like to clarify these knowledge gaps, as well as appeal to a wider variety of third party content providers; this may include travel planning and review sites and travel bloggers, which may reach a more diverse audience of travelers and clinicians.
CDC has an interest in supporting third party users, as they can expand the reach of TH content; they often credit CDC as the source of this information; and their users may consider CDC a trustworthy information source. The added reach of these third party users is even more important during disease outbreaks, when recommendations are subject to change frequently and the number of locations affected can grow rapidly, as was the case with the Ebola and Zika outbreaks. We think that we can increase the utility of our current information and extend the reach of our health messaging by offering more tailored solutions for external content providers that allow them to easily repackage and utilize CDC information.
It is currently unclear what the ideal solution would be to best fit the needs of the third party content provider audience we are hoping to engage. We desire feedback from these stakeholders about how best to optimize CDC content for their customers, and mechanisms by which they would prefer to receive and engage with CDC content. We hope to gain insights into best practices for delivering timely, accurate information to third party users that can easily be distributed to the traveler and clinician audiences.
This request seeks OMB approval for a GenIC to conduct semi-structures interviews. The project team at DGMQ/NCEZID hopes to capture information about how the respondent prioritizes, seeks, and uses travel health information; how the respondent’s company engages with CDC content; and what opportunities and challenges the respondent’s company faces in providing health information to travelers. The efforts of CDC activities is authorized under Section 301 of the Public Health Service Act 42 U.S.C.241.
The CDC I-Catalyst program guides participants through a “customer discovery” process aimed at helping teams with a new solution to identify their customers. This is done by taking a team’s main assumptions about who their customer is, the exact problem they are solving for the customer, and how the customer wants to receive or use the solution from the team—and turning those assumptions into hypotheses which the teams will then test (mainly through interviews with potential customers). Only conversations with potential customers (stakeholders) can provide the facts from which hypotheses are proven or disproven about whether a solution (product, process, etc.) creates value for the intended beneficiaries. It is expected that participants will leave the program with the ability to evaluate and translate their insights into solutions that have high levels of efficacy and user acceptability. The information collection is necessary to guide CDC project teams to create usable solutions that are customer centric and meaningful to users, whether it’s adhering to recommendations, policies, protocol or interventions.
The goal of this project, which is nested within the I-Catalyst training program, is to solicit qualitative information from specific stakeholder groups to help identify new solutions to Travelers Health content delivery challenges. This is done by identifying key assumptions and gaps in knowledge about the type of content solutions that stakeholders are currently using as a means of informing what types of solutions are needed. One goal of this project is to question the specific assumptions our team has identified to see if they are correct, which will ultimately serve to inform the solution(s) pursued as a result of the stakeholder discovery process.
The Travelers Health team intend to solicit qualitative information from specific stakeholder groups that are part of the travel planning and preparation process travelers currently use. These stakeholders may include: travel writers and bloggers; any individuals involved in developing and promoting travel-related website or apps; travel agents; and other groups in the international travel industry. We seek to discover from them what their current practices are for content generation and delivery, and what their priorities and challenges are for maximizing the value of their products to their customers. TH also want to find out from these stakeholders if they are currently consuming and using TH content to inform travelers during the travel planning process, and if so, if there are ways that we can reach more people and make our content more useful by publishing it in new or different ways.
This information will be utilized internally by TH to inform our efforts at understanding the role that travel health information currently plays within the travel planning process of travelers, as well as the ecosystem of travel media sources (e.g. print media, websites, and apps). This understanding is important for helping TH achieve a larger objective of growing the number of international travelers who receive actionable travel health information before, during, and after their trips. The information collected will be used for internal CDC decision making and planning purposes as well as to provide suggestions for improving travelers’ health services in support of development of public health solutions. The customer interviews will be conducted with product developers, marketing managers, and content managers in the travel industries, who have direct access to the international traveler audience. Based on the information gathered, CDC can work effectively with the industry to easily get evidence-based recommendations to travelers and decrease avoidable travel-associated illnesses and infectious disease threats to the U.S.
The information gained through the interviews will be used to inform our efforts at understanding the role that travel health information currently plays within the travel planning process of travelers, as well as the ecosystem of travel media sources (e.g. print media, websites, and apps). This understanding is important for helping TH achieve a larger objective of growing the number of international travelers who receive actionable travel health information before, during, and after their trips. Generalization of team results is not intended.
The interviews will be conducted in person, on-site or by virtual video conferencing like Skype for Business or Adobe Connect (Att. 1 – Interview guide). Using formative interview protocols allows the interviewer to follow the respondent’s lead during in-person conversations. This wouldn’t be possible if a list of fixed questions were used. This also is not possible if automated, technological-based collection techniques, such as a web-based survey, are used. On-site, in-person interviews allow interviewers to establish rapport with respondents and produce visual cues for interpreting responses that may require further probing or clarification. However, there are instances where teams can use improved information technology such as Skype or video conferencing for interviews to reduce the burden and provide flexibility in responder’s schedule.
This is a unique I-Catalyst project and a new proposed solution. There is no existing database that can capture information about how the respondent prioritizes, seeks, and uses travel health information; how the respondent’s company engages with CDC content; and what opportunities and challenges the respondent’s company faces in providing health information to travelers.
No small businesses will be involved in this project.
Data is collected once at this stage in the discovery process, respondents will participate in an interview once lasting no more than 30 minutes.
This request fully complies with the regulation 5 CFR 1320.5. There are no special circumstances.
Not Applicable
There is no exchange of payment or gifts to respondents for the voluntary interviews.
Activities for this request do not involve the collection of Individually Identifiable Information.
Activities for this request do not involve the collection of Individually Identifiable Information. CDC Human Research Protection Office determined that data IC is not research involving human subjects and IRB is not required - OADS Project Determination approval.
The project team will interview 50 respondents for this ICR. The project will interview respondents for an average of 30 minutes and maximum of 1 responses per respondent. Annualized burden will be 25 hours and an estimated annualized burden cost of $794.75.
Estimated Annualized Burden Hours
Table A: Estimated Annualized Burden Hours
Type of Respondents |
Form Name |
No. of Respondents |
No. of Responses per Respondent |
Avg. Burden per Response (in hrs.) |
Total Burden (in hrs.) |
Marketing & Content Managers, Developers in travel industry |
Interview Guide |
50 |
1 |
30/60 |
25 |
Total |
|
25 |
Table B: Estimated Annualized Burden Costs
Type of Respondents |
Form Name |
No. of Respondents |
No. of Responses per Respondent |
Avg. Burden per Response (in hrs.) |
Total Burden (in hrs.) |
Hourly Wage Rate* |
Total Respondent Costs |
|
|
|
|||||
Marketing & Content Managers, Developers in travel industry |
Interview Guide |
50 |
1 |
30/60 |
25 |
Average 31.79
|
$794.75 |
|
|
|
|
|
|
|
$ 794.75 |
*Average of hourly wage from http://www.bls.gov/home.htm
There are no projected cost burdens for reporting.
The project cost is associated with the CDC project team members responsible for conducting the interviews. These figures were estimated as the sum of the anticipated direct labor; fringe and burden on direct labor.
Project Staff Oversight |
Annual Cost |
CDC Cost: Health Scientist (5% of Time) |
$5,000.00 |
CDC Cost: PH Communication Specialists (2% of Time) |
$1,420.00 |
Total |
$6,420.00 |
This information collection request is a new submission.
The proposed interviews will be conducted within 3-6 months after approval of GenIC. Interim reports will be developed, which will incorporate data collected from these sources in 2017 and 2018.
The display of the OMB expiration date is not inappropriate.
There are no exceptions to the certification statement.
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
File Title | I-Catalyst Program - Travelers Health with Travel Industry |
Subject | GenIC Submission under OMB #0920-1158 |
File Modified | 0000-00-00 |
File Created | 2021-01-21 |